Small molecule inhibition of non-canonical (TAK1-mediated) BMP signaling results in reduced chondrogenic ossification and heterotopic ossification in a rat model of blast-associated combat-related lower limb trauma

被引:13
|
作者
Strong, Amy L. [1 ]
Spreadborough, Philip J. [2 ,3 ,4 ]
Pagani, Chase A. [1 ]
Haskins, Ryan M. [2 ]
Dey, Devaveena [2 ,3 ]
Grimm, Patrick D. [2 ,3 ]
Kaneko, Keiko [1 ]
Marini, Simone [1 ]
Huber, Amanda K. [1 ]
Hwang, Charles [1 ]
Westover, Kenneth [5 ,6 ]
Mishina, Yuji [7 ]
Bradley, Matthew J. [2 ,3 ]
Levi, Benjamin [1 ]
Davis, Thomas A. [2 ,3 ]
机构
[1] Univ Michigan, Dept Surg, Div Plast Surg, Ann Arbor, MI 48109 USA
[2] Naval Med Res Ctr, Regenerat Med Dept, Silver Spring, MD USA
[3] Uniformed Serv Univ Hlth Sci, Dept Surg, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA
[4] Acad Dept Mil Surg & Trauma, Royal Ctr Def Med, Birmingham, W Midlands, England
[5] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
[6] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA
[7] Univ Michigan, Sch Dent, Dept Biol & Mat Sci & Prosthodont, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
TAK1; TGF-beta activated kinase 1; Non-canonical TGF-beta signaling; Heterotopic ossification; Blast injury model; Chondrogenic differentiation; GROWTH-FACTOR-BETA; TISSUE PROGENITOR CELLS; ACTIVATED KINASE 1; OSTEOGENIC DIFFERENTIATION; TAK1; MAPK; RADIOTHERAPY; CASUALTIES; EXCISION; IRAQ;
D O I
10.1016/j.bone.2020.115517
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heterotopic ossification (HO) is defined as ectopic bone formation around joints and in soft tissues following trauma, particularly blast-related extremity injuries, thermal injuries, central nerve injuries, or orthopaedic surgeries, leading to increased pain and diminished quality of life. Current treatment options include pharmacotherapy with non-steroidal anti-inflammatory drugs, radiotherapy, and surgical excision, but these treatments have limited efficacy and have associated complication profiles. In contrast, small molecule inhibitors have been shown to have higher specificity and less systemic cytotoxicity. Previous studies have shown that bone morphogenetic protein (BMP) signaling and downstream non-canonical (SMAD-independent) BMP signaling mediated induction of TGF-beta activated kinase-1 (TAK1) contributes to HO. In the current study, small molecule inhibition of TAK1, NG-25, was evaluated for its efficacy in limiting ectopic bone formation following a rat blast associated lower limb trauma and a murine burn tenotomy injury model. A significant decrease in total HO volume in the rat blast injury model was observed by microCT imaging with no systemic complications following NG-25 therapy. Furthermore, tissue-resident mesenchymal progenitor cells (MPCs) harvested from rats treated with NG-25 demonstrated decreased proliferation, limited osteogenic differentiation capacity, and reduced gene expression of Tac1, Col10a1, Ibsp, Smad3, and Sox2 (P < 0.05). Single cell RNA-sequencing of murine cells harvested from the injury site in a burn tenotomy injury model showed increased expression of these genes in MPCs during stages of chondrogenic differentiation. Additional in vitro cell cultures of murine tissue-resident MPCs and osteochondrogenic progenitors (OCPs) treated with NG-25 demonstrated reduced chondrogenic differentiation by 10.2-fold (P < 0.001) and 133.3-fold (P < 0.001), respectively, as well as associated reduction in chondrogenic gene expression. Induction of HO in Tak1 knockout mice demonstrated a 7.1-fold (P < 0.001) and 2.7-fold reduction (P < 0.001) in chondrogenic differentiation of murine MPCs and OCPs, respectively, with reduced chondrogenic gene expression. Together, our in vivo models and in vitro cell culture studies demonstrate the importance of TAK1 signaling in chondrogenic differentiation and HO formation and suggest that small molecule inhibition of TAK1 is a promising therapy to limit the formation and progression of HO.
引用
收藏
页数:12
相关论文
empty
未找到相关数据